Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research Article Volume 4 Issue 3

Anaemia in HIV-Infected Children in A National Referral Hospital in Uganda: Prevalence and Associated Factors

Mary Munyagwa1,2*, Edison A Mworozi1, Grace Ndeezi1, Yusuf Mulumba3 and Francis Ssali4

1Makerere University College of health Sciences, Uganda
2Kagando Hospital, Uganda
3Uganda- CWRU Research Collaboration, Uganda
4Joint Clinical Research Center, Uganda

*Corresponding Author: Mary Munyagwa, Makerere University College of health Sciences and Kagando Hospital, Uganda.

Received: December 27, 2019; Published: February 08, 2020



Objective: Anaemia is a common complication of HIV infection affecting clinical outcome. The aim of this study was to determine the prevalence and identify factors associated with moderate to severe anaemia in HIV infected children.

Methods: This cross sectional study included 215 HIV infected children aged 6 months to 12 years. Epidemiological and clinical characteristics were recorded and a blood sample analyzed for anaemia. Multivariate logistic regression was done to determine factors associated with anaemia.

Results: Of the 215 children studied, 112 (52.1%) were males and 103 (47.9%) were females. The prevalence of anaemia was 50.7% with children aged 6 to 24 months being most affected. Factors associated with anaemia were age < 60 months (OR 4.51, p = 0.002), not taking multivitamin supplementation (OR 4.67, p = < 0.001), previous transfusion (OR 3.97,p = 0.006) and malaria co-infection (OR 4.42, p = 0.002).

Conclusions: Moderate to severe anaemia is highly prevalent among HIV infected children especially those aged 24 months and younger. HIV-infected children should be routinely evaluated for presence of anaemia, malaria prophylaxis should be stressed and more studies should be done to evaluate the impact of multivitamin supplementation on the hematological status of HIV-infected children.

Keywords: HIV-Infected; A National Referral Hospital



  1. WHO. Focusing on anaemia: Towards an integrated approach for effective anaemia control (2004).
  2. Moore RD. “Human immunodeficiency virus infection, anaemia and survival”. Clinical Infectious Diseases 29 (1999):  44-49.
  3. Belperio PS and Rhew DC. “Prevalence and outcomes of anaemia in individuals with human immunodeficiency virus: a systematic review of literature”. The American Journal of Medicine 116 (2004): 27S-43S.
  4. Calis JCJ., et al. “HIV-associated anaemia in children: a systematic review from a global perspective”. AIDS 22 (2008): 1099-1112.
  5. Brabin JB., et al. “Iron deficiency anaemia: reexamining the nature and magnitude of the public health problem”. Journal of Nutrition 131(2001):  636S-648S.
  6. Semba RD. “Iron deficiency anemia and the cycle of poverty among Human immunodeficiency virus infected women in the inner city”. Clinical Infectious Diseases 37(2003): S105-11.
  7. Totin D., et al. “Iron Deficiency Anaemia is Highly Prevalent among Human Immunodeficiency Virus-Infected and Un infected Infants in Uganda”. Journal of Nutrition 132(2002): 423-429.
  8. Bachou H., et al. “Risk factors in hospital deaths in severely malnourished children in Kampala Uganda”. BMC Pediatrics 6 (2006): 7-16.
  9. Eley BS., et al. “A prospective cross-sectional study of anaemia and peripheral iron status in antiretral naive ,HIV-1 infected children in Cape Town, South Africa”. BMC Infectious Diseases 2(2002):  3.
  10. Mocroft A., et al. “Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe”. AIDS 13(1999): 943-950.
  11. Clark TD., et al. “Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda”. Annals of Tropical Paediatrics Annals of Tropical Paediatrics 22(2002):  11-17.
  12. Semba RD and Glenda EG. “Pathogenesis of anaemia During Human Immunodeficiency Virus Infection”. Journal of Investigative Medicine 49(2001): 225-239.
  13. Claster S. “Biology of Anemia, Differential Diagnosis, and Treatment Options in Human Immunodeficiency Virus Infection”. The Journal of Infectious Disease 185(2002): S105-9.
  14. Kreuzer K-A and Rockstroch JK. “Pathogenesis and pathophysiology of anaemia in HIV -infection”. Annals of Haematology 75 (1997): 179-187.
  15. Bain BJ. “The haematological features of HIV infection”. British journal of Haematology 99(1997): 1-8.
  16. Volberding PA., et al. “Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies”. Clinical Infectious Diseases 38 (2004): 1454-63.
  17. Moore RD and Forney D. “Anaemia in HIV-infected patients receiving highly active antiretroviral therapy”. Journal of Acquired Immune Deficiency Syndromes 29 (2002): 54-57.
  18. Hedberg K., et al. “Plasmodium falciparum-associated anaemia in children at a large urban hospital in Zaire”. The American Journal of Tropical Medicine and Hygiene 48 (1993): 365-371.
  19. Premji Z., et al. “Anaemia and plasmodium falciparum infection among young children in an holoendemic area, Bagamoyo, Tanzania”. Acta Tropica 59 (1995): 55-64.
  20. Moses AV., et al. “Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors”. Blood 87 (1996): 919-925.
  21. Kahigwa E., et al. “Risk factors for presentation to hospital with severe anaemia in Tanzanian children: a case control study”. Tropical Medicine and International Health 7 (2002): 823-830.
  22. Shet A., et al. “Anemia and growth failure among HIV-infected children in India: a retrospective analysis”. BMC Pediatrics 9 (2009): 37.
  23. Van Eijik AM., et al. “Malaria and human immunodeficiecy virus infection as risk factor for anaemia in infants in Kisumu, Western Kenya”. The American Journal of Tropical Medicine and Hygiene 67 (2002): 44-53.
  24. Davenport GC., et al. “Haematological predictors of increased severe anaemia in Kenyan Children co-infected with plasmodium falciparum and HIV-1”. American Journal of Hematology 85 (2010): 227-233.
  25. Korenromp EL., et al. “Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa”. Emerging Infectious Diseases 11(2005): 1410-1418.
  26. Laufer MK., et al. “Impact of HIV-Associated Immunosuppression on Malaria Infection and Disease in Malawi”. The Journal of Infectious Diseases 193 (2006):  872-878.
  27. Othieno RO., et al. “Increasing severe anaemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria”. AIDS 20 (2006):  275-280.
  28. Mulamba S., et al. “The effect of HIV on morbidity and mortality in children with severe malarial anaemia”. Malaria Journal 6 (2007): 143.
  29. Fawzi WW., et al. “A randomised trial of multivitamin supplementation and HIV disease progression and mortality”. New England Journal of Medicine 351 (2004): 23-32.
  30. FawziI WW., et al. “Multivitamin supplimentation improves hematological status in HIV-infected women and their children in Tanzania”. The American Journal of Clinical Nutrition 85 (2007):  1335-1343.


Citation: Mary Munyagwa., et al. “Anaemia in HIV-Infected Children in A National Referral Hospital in Uganda: Prevalence and Associated Factors". Acta Scientific Medical Sciences 4.3 (2020): 34-40.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US